Saltar al contenido principal
World Congress on Medical Oncology
Olympic Paris 2024
Test 4
Test 1
Test 2
Test 5
Test 3
Test clone mv
Olympic Paris 2024
Olympic Paris 2024 - VIP - Boss Ticket
Olympic Paris 2024
Finance Code Test
Concrete Institute of Australia’s Biennial National Conference 2025
Concrete Institute of Australia’s Biennial National Conference 2025
Test Goldenowl Conference
Virtual Event 01
Paris Olypmpic Clone 12.09 webinar
7th World Congress of Nanoentomology
NDS NAB Transact testing
JC test 01
Pre-Release 3 Oct
DEX (Digital Employee Experience) conference 2024
test derek
TimeZone Test
TimeZone Test
Talent Events
Event Demo
Olympic Paris 2024 x
original event name for cloning testing
Olympic Paris 2024
Default payment method test
evexus Event - 509
Default payment method test2
Test Worker
Test Worker
charlie test
Arinex 1
NET24 Ho Chi Minh City Workshop 2024
Telefilm 2024 - International Exhibition of Film and Television Technology in Vietnam
Olympic Paris 2024
charlie test 2711
charlie test 2711 cloned
CICM SecurePay testing
The AI Submit 2024
Test webinar 04.12 - - - -
Taylor Swift Clone 04
Taylor Swift Clone 02
Taylor Swift
Taylor Swift Clone
Taylor Swift Clone 01
Import Test
The Trading Summit 2024 (HCM - Vietnam)
Electric Dreams: A Synthwave Extravaganza
Taylor Swift 16
Taylor Swift 12
Taylor Swift 14
Taylor Swift 15
Taylor Swift 17
Taylor Swift 20
Coin Based Hackathon 2024
Rose 01
Import Ticket
Vu Cat Tuong
STEM 1
Kids STEM
CLONE Innovate 2025: A Future Forward Summit
Innovate 2025: A Future Forward Summit
Petals & Sunshine Festival
webinar 05/02
Science
evexus Event - 273
evexus Event - 275
Association webinar 5.2
evexus Event - 274
Aurora Nights 2025 - Webinar
Seoul AI Seminar
Webinar Event - Lily AI - 20/02
evexus Event - 287
Taylor Swift 11
Swifties Only Social Contact
cloned event for Bree QA
evexus Event - 288
evexus Event - 289
Bree QA event
Tim's event
Ralph's event
Tim cloned enable all
Ralph clone event the last one
Hawaii AI Seminar
evexus Event - 293
Tokyo Seminar
Indiana AI Seminar
Registration ticket 2025
TechNova Summit
Event - 28 - 03 - 2025
TechNova Summit [2]
TechNova Summit [3]
Tech v1
Event 28/03/2025
Job Affairs
Fan Job
Webinar Event - Lily AI - 04/03
Event Registration
Association webinar 20.2
Fan's stock query
Registration
Aurora Nights 2025
Ralph test email
Taylor Swift 13
The Core 2025
Rose
The Thirdweb submit
Stress Test Conference 2026
Alan'event
World Congress of Medical Oncology
The AI Seoul Submit 2026
The Core 2026
Los horarios se muestran en su zona horaria local GMT
Outcomes in SSRF; Experience in a Level 1 Trauma Centre
Verbal Presentation

Verbal Presentation

10:37 am

03 May 2026

Meeting Room M7

RESEARCH PAPERS

Talk Descripción

Institución: Royal Perth Hospital - WA, Australia

Purpose: To describe early and medium-term outcomes following SSRF implementation over 7 years in a level 1 trauma centre, as management of severe blunt chest wall trauma. Methodology: A retrospective review was conducted over the previous 7 years at Royal Perth Hospital SMTU. Patients were identified using theatre coding, and a variety of variables were collected via imaging, clinical notes and DMR. Collected variables included demographics, mechanism of injury, injury severity, chest wall morphology, timing and indications for fixation, ventilatory days post‐fixation, tracheostomy, pulmonary and wound complications, mortality, and documented clinical or radiological short-term outcomes. Results: The cohort was comprised of patients with more than 10 rib fractures secondary to high-energy blunt force chest trauma following motor vehicle and motorbike crashes. Common indications for SSRF were chest wall deformity, clinical or radiological flail, or respiratory failure despite maximal conservative management. SSRF was carried out within 72 hours of arrival at RPH in most cases. Ventilatory duration post fixation varied from no requirement to prolonged courses requiring tracheostomy, commonly in the context of associated traumatic brain injury. Complications occurred in a substantial minority. Mortality reflected overall injury burden and treatment‐limitation decisions rather than chest wall injury alone. Among patients with available follow‐up, most demonstrated satisfactory healing and functional recovery. Conclusion: In this level 1 trauma centre, SSRF for severe blunt chest wall trauma was associated with acceptable complication rates, low procedure‐related mortality and favourable functional outcomes, supporting its continued use within a structured protocol and providing a foundation for future comparative effectiveness studies.
Speakers
Contributors
Authors

Dr Cormac Mulhall - , Dr Julia Shearer - , Dr Rohit Sarvepalli - , Dr Sana Nasim - , Prof Dieter Weber -

Otro Sugerido Talks
Privacy Statement Header

By confirming your acceptance below, you agree to our Privacy Policy